These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 19821192)
1. U.S. pharmacy policy: a public health perspective on safety and cost. Rosenau PV; Lal LS; Glasser JH Soc Work Public Health; 2009; 24(6):543-67. PubMed ID: 19821192 [TBL] [Abstract][Full Text] [Related]
3. Potential public sector cost-savings from over-the-counter access to oral contraceptives. Foster DG; Biggs MA; Phillips KA; Grindlay K; Grossman D Contraception; 2015 May; 91(5):373-9. PubMed ID: 25732570 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical counseling: Between evidence-based medicine and profits. Egorova SN; Akhmetova T Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727 [TBL] [Abstract][Full Text] [Related]
5. Direct-to-consumer advertising of prescription drugs. Frosch DL; Grande D LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541 [TBL] [Abstract][Full Text] [Related]
6. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Singer M; Baer HA; Scott G; Horowitz S; Weinstein B Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813 [TBL] [Abstract][Full Text] [Related]
8. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Mintzes B; Barer M; Lexchin J; Bassett KL Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical cost management and access to psychotropic drugs: the U.S. context. Huskamp HA Int J Law Psychiatry; 2005; 28(5):484-95. PubMed ID: 16150490 [TBL] [Abstract][Full Text] [Related]
10. Switching from prescription to over-the counter medications: a consumer and managed care perspective. Pawaskar MD; Balkrishnan R Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652 [TBL] [Abstract][Full Text] [Related]
11. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis. Sullivan PW; Follin SL; Nichol MB Med Care; 2003 Dec; 41(12):1382-95. PubMed ID: 14668671 [TBL] [Abstract][Full Text] [Related]
12. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
13. Direct-to-consumer advertising of prescription medications: Do you see what the public sees? Hampl JS; Bramlett-Solomon S; Wharton CM J Am Diet Assoc; 2006 Dec; 106(12):1937-40, 1942-3, 1945-6. PubMed ID: 17126621 [No Abstract] [Full Text] [Related]
14. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns]. Cianciara D Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020 [TBL] [Abstract][Full Text] [Related]
15. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
16. Prescription to over-the-counter deregulation in Canada: are we ready for it, or do we need to be? Lynd LD; Taylor J; Dobson R; Willison DJ CMAJ; 2005 Sep; 173(7):775-7. PubMed ID: 16157708 [No Abstract] [Full Text] [Related]
17. Drug laws--state to comply... but later. Bateman C S Afr Med J; 2004 Aug; 94(8):605-6, 608. PubMed ID: 15352576 [No Abstract] [Full Text] [Related]
18. Managing prescription drug costs. Sica JM Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515 [TBL] [Abstract][Full Text] [Related]
19. The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safety. Lo Re V; Strom BL Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):818-25. PubMed ID: 17436357 [TBL] [Abstract][Full Text] [Related]